Global Clinical Trial Reveals Safest, Most Effective Antibiotics for Golden Staph Bloodstream Infections
Cefazolin had similar 90-day mortality and fewer kidney injuries than standard penicillins in nearly 1,300 patients, researchers said.
6 Articles
6 Articles
Medical Xpress
hmri.org.auGlobal clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections
An international clinical trial has identified the optimal antibiotics for golden staph bloodstream infections, a breakthrough set to reshape treatment for the life-threatening condition. The SNAP Trial found that the standard antibiotic, flucloxacillin, should no longer be the drug of choice for treating the infection, revealing that cefazolin and benzylpenicillin offer safer and equally effective alternatives for patients.
The molecule most commonly used to treat blood infections caused by Staphylococcus aureus is not the best choice and at least two other equally effective and potentially safer alternatives are available, demonstrating work involving Montreal researchers.
Cefazolin Proves Its Mettle for Methicillin-Susceptible Staph Infections
(MedPage Today) -- Cefazolin was effective for the treatment of bacteremia caused by methicillin-susceptible Staphylococcus aureus (MSSA), findings of an international open-label platform trial showed. Among patients hospitalized with penicillin...
The molecule most commonly used to treat blood infections caused by Staphylococcus aureus is not the best choice and at least two other equally effective and potentially safer alternatives are available, demonstrating work involving Montreal researchers.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
